Flu

Maryland technology development agency awards grant to study stem cells for improving flu vaccine

Maryland technology development agency awards grant to study stem cells for improving flu vaccine

The Maryland Technology Development Corp. has awarded a $750,000 grant to Longeveron LLC, a Miami-based biopharmaceutical company, to study whether stem cells can make a better flu vaccine for seniors with a researcher from Johns Hopkins University School of Medicine.

Dr. Sean Leng, an associate professor in the school’s division of geriatric medicine and gerontology, and his team will conduct a clinical trial with Longeveron to examine the safety and efficacy of one of its stem-cell products to improve the immune-response to the flu vaccine in frail, elderly patients, the company announced today.

Seniors are often the hardest hit by seasonal influenza and its complications,...

77°